Metabolic Syndrome

But GI side effects higher than other comparable anti-obesity agents

Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose

Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease

Daily orforglipron also lowered HbA1c in type 2 diabetes

Survivors on aromatase inhibitors lost significantly less weight

Clinicians should not rely solely on BMI for measuring obesity, researcher says

News and commentary from the endocrinology world

News and commentary from the endocrinology world

News and commentary from the endocrinology world

Patients had lower odds of lipid, cardio, or diabetes drug prescriptions for up to 15 years

News and commentary from the endocrinology world

Overall, nearly half dropped below threshold for obesity

News and commentary from the endocrinology world

News and commentary from the endocrinology world